Sanofi&39;s Libtayo Lands In EU With Skin Cancer Nod
Sanofi's Libtayo Lands In EU With Skin Cancer Nod
08:41 EDT 2 Jul 2019 |
SCRIP
Nine months after the US approval, the EU has followed suit and given a conditional approval for Sanofi and Regeneron’s...
Original Article: Sanofi's Libtayo Lands In EU With Skin Cancer Nod
More From BioPortfolio on "Sanofi's Libtayo Lands In EU With Skin Cancer Nod"